Compare Ginkgo Bioworks Holdings Inc (DNA) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Schlumberger NV — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Schlumberger NV trades at $53.7 (market cap $79.67B). The key difference: Schlumberger NV is far larger — about 157.5× Ginkgo Bioworks Holdings Inc's market cap, and Schlumberger NV pays a 2.2% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | SLB | |
|---|---|---|
Market Cap | $505.73M | $79.67B |
Sector | Health | Energy |
52-Week High | $16.14 | $58.01 |
52-Week Low | $5.48 | $31.72 |
Enterprise Value | $607.68M | $88.40B |
Dividend Yield | — | 2.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
